These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 4881517)

  • 21. Some observations on the alteration of the adhesiveness of human blood platelets after infusion with low molecular weight dextran.
    Lal HB; Caroli RK; Sengupta D; Basumalik SN; Khan MA; Malik RN; Warrik HP
    J Assoc Physicians India; 1968 Aug; 16(8):523-7. PubMed ID: 5700157
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical effectiveness of polyglucin in myocardial infarction complicated by collapse].
    Doroshenko GL
    Vrach Delo; 1967 Nov; 11():31-4. PubMed ID: 5621426
    [No Abstract]   [Full Text] [Related]  

  • 23. Fibrinolytic drugs in acute myocardial infarction.
    Drug Ther Bull; 1988 Jun; 26(12):45-8. PubMed ID: 3292184
    [No Abstract]   [Full Text] [Related]  

  • 24. Prophylaxis of ventricular dysrhythmias following acute myocardial infarction: a double-blind trial of continuous intravenous infusion of lignocaine.
    Baker IA; Collins JV; Evans TR
    Guys Hosp Rep; 1971; 120(1):1-7. PubMed ID: 4934490
    [No Abstract]   [Full Text] [Related]  

  • 25. Initial experience with the low-molecular-weight heparin, enoxaparin, in combination with the platelet glycoprotein IIb/IIIa blocker, tirofiban, in patients with non-ST segment elevation acute coronary syndromes.
    Cohen M
    J Invasive Cardiol; 2000 Dec; 12 Suppl E():E5-9;discussion E25-8. PubMed ID: 11156722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversal by phenylephrine of the beneficial effects of intravenous nitroglycerin in patients with acute myocardial infarction.
    Come PC; Flaherty JT; Baird MG; Rouleau JR; Weisfeldt ML; Greene HL; Becker L; Pitt B
    N Engl J Med; 1975 Nov; 293(20):1003-7. PubMed ID: 809711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The treatment of atherosclerotic peripheral arterial insufficiency with low molecular weight dextran intravenously.
    Lewis SR; Johnson JB
    J Natl Med Assoc; 1966 Jul; 58(4):261-4. PubMed ID: 5947681
    [No Abstract]   [Full Text] [Related]  

  • 28. [Prolonged use of intravenous nitro derivatives in acute myocardial infarction (AMI)].
    Borghi E; Roventini L; Vecce R; Schembri S; Maurini V; Giomi N; Cantini R; Rindi M; Lenzi R; Barzi F
    Minerva Cardioangiol; 1989 Jun; 37(6):307-9. PubMed ID: 2812448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Stimulation of the lymphatic drainage in intensive care of acute myocardial infarct].
    Mamedov IaD; Kurbanov IaZ; Garaev GSh; Kuliev EA; Abdullaev FM
    Anesteziol Reanimatol; 1993; (1):32-4. PubMed ID: 7524379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Editorial: Lidocaine: prophylactic value in myocardial infarction.
    Hussey HH
    JAMA; 1975 Feb; 231(6):627. PubMed ID: 1089823
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of acute myocardial infarct using dipyridamole in continuous venoclysis].
    Nolla Panadés J
    Rev Clin Esp; 1970 Jun; 118(1):73-80. PubMed ID: 5457397
    [No Abstract]   [Full Text] [Related]  

  • 32. [Electrocardiography and serum CK-MB determination in myocardial infarction and reperfusion in patients treated with intravenous streptokinase or placebo].
    Clemmensen PM; Grande P; Saunamäki K; Granborg J; Svendsen JH; Pedersen F; Haedersdal C; Madsen JK; Wagner GS
    Ugeskr Laeger; 1993 Jan; 155(1):36-40. PubMed ID: 8421847
    [No Abstract]   [Full Text] [Related]  

  • 33. [Use of a non-opiated analgesic during the acute stage of myocardial infarction].
    Masquet C; Gourgon R; Bouvrain Y
    Therapeutique; 1973; 49(7):479-81. PubMed ID: 4362539
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of arrhythmias with practolol (Eraldin)].
    Bach-Mortensen N
    Ugeskr Laeger; 1973 Sep; 135(37):1988-92. PubMed ID: 4129852
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical experiences with the use of carbochromen in coronary syndrome].
    Ivancić R; Persić T; Custović F
    Arzneimittelforschung; 1970 Mar; 20():454-6. PubMed ID: 4916580
    [No Abstract]   [Full Text] [Related]  

  • 36. Low molecular weight heparin for treatment of acute myocardial infarction (FAMI): Fragmin (dalteparin sodium) in acute myocardial infarction.
    Kakkar VV; Iyengar SS; De Lorenzo F; Hargreaves JR; Kadziola ZA;
    Indian Heart J; 2000; 52(5):533-9. PubMed ID: 11256775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of death from recurrent ischemic events after intravenous streptokinase in acute myocardial infarction: results from the Intravenous Streptokinase in Myocardial Infarction (ISAM) Study.
    Schröder R; Neuhaus KL; Linderer T; Leizorovicz A; Wegscheider K; Tebbe U
    Circulation; 1987 Aug; 76(2 Pt 2):II44-51. PubMed ID: 3301056
    [No Abstract]   [Full Text] [Related]  

  • 38. [Use of isosorbide dinitrate (isoket) in stenocardia and myocardial infarction].
    Polotskaia EL; Akopian LM; Karavaeva IP; Semenova LA; Krasina GF
    Klin Med (Mosk); 1985 Aug; 63(8):36-41. PubMed ID: 3908808
    [No Abstract]   [Full Text] [Related]  

  • 39. Intramuscular lidocaine for prevention of lethal arrhythmias in the prehospitalization phase of acute myocardial infarction.
    Koster RW; Dunning AJ
    N Engl J Med; 1985 Oct; 313(18):1105-10. PubMed ID: 3900727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of low molecular weight dextran in peripheral arterial disease.
    Hardy DA; Klippel AP
    Am Surg; 1969 Jul; 35(7):468-70. PubMed ID: 5785907
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.